Brief: Outlook Therapeutics Appoints Biopharmaceutical Industry And Commercial Leader Bob Jahr As Chief Executive Officer
01/07/2025 13:06
July 1 (Reuters) - Outlook Therapeutics Inc OTLK.O: OUTLOOK THERAPEUTICS APPOINTS BIOPHARMACEUTICAL INDUSTRY AND COMMERCIAL LEADER BOB JAHR AS CHIEF EXECUTIVE OFFICER OUTLOOK THERAPEUTICS INC - LAWRENCE A. KENYON TO CONTINUE AS CFO AND BOARD MEMBER OUTLOOK THERAPEUTICS INC - BOB JAHR APPOINTED TO OUTLOOK THERAPEUTICS BOARD Source text: ID:nGNX9zNygw Further company coverage: OTLK.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Outlook Therapeutics
See all newsBrief: Outlook Therapeutics Appoints Kevin Lundquist As Chief Financial Officer As It Prepares For U.S. Commercial Launch Of Lytenava™
Outlook Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Outlook Therapeutics Q3 net loss narrows slightly as costs drop
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce